Piramal Pharma Limited — Dividend/Bonus, 14-05-2025: Dividend

Piramal Pharma has announced a board meeting on May 14, 2025. The financial results for the quarter and half-year report a standalone net profit of Rs. 691.4 Cr (EPS Rs. 5.22) and consolidated net profit of Rs. 91.13 Cr (EPS Rs. 0.69). The Board has proposed a final dividend of Rs. 0.14 per share, payable after shareholder approval at the AGM. Leadership update: Mr. Neeraj Bharadwaj resigned and Mr. Amit Jain joined as Non-Executive, Non-Independent Director.